112 related articles for article (PubMed ID: 35605406)
1. Highly polymerized proanthocyanidins (PAC) components from blueberry leaf and stem significantly inhibit SARS-CoV-2 infection via inhibition of ACE2 and viral 3CLpro enzymes.
Sugamoto K; Tanaka YL; Saito A; Goto Y; Nakayama T; Okabayashi T; Kunitake H; Morishita K
Biochem Biophys Res Commun; 2022 Jul; 615():56-62. PubMed ID: 35605406
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of adult T-cell leukemia cell proliferation by polymerized proanthocyanidin from blueberry leaves through JAK proteolysis.
Ichikawa T; Sugamoto K; Matsuura Y; Kunitake H; Shimoda K; Morishita K
Cancer Sci; 2022 Apr; 113(4):1406-1416. PubMed ID: 35100463
[TBL] [Abstract][Full Text] [Related]
3. Reduction of Enteric Viruses by Blueberry Juice and Blueberry Proanthocyanidins.
Joshi SS; Howell AB; D'Souza DH
Food Environ Virol; 2016 Dec; 8(4):235-243. PubMed ID: 27299641
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Proanthocyanidin Content in Rabbiteye Blueberry (
Toyama Y; Fujita Y; Toshima S; Hirano T; Yamasaki M; Kunitake H
Plants (Basel); 2023 Feb; 12(4):. PubMed ID: 36840296
[TBL] [Abstract][Full Text] [Related]
5. Antiviral effects of blueberry proanthocyanidins against Aichi virus.
Joshi SS; Howell AB; D'Souza DH
Food Microbiol; 2019 Sep; 82():202-208. PubMed ID: 31027775
[TBL] [Abstract][Full Text] [Related]
6. In silico analysis and identification of antiviral coumarin derivatives against 3-chymotrypsin-like main protease of the novel coronavirus SARS-CoV-2.
Abdizadeh R; Hadizadeh F; Abdizadeh T
Mol Divers; 2022 Apr; 26(2):1053-1076. PubMed ID: 34213728
[TBL] [Abstract][Full Text] [Related]
7. An albumin-angiotensin converting enzyme 2-based SARS-CoV-2 decoy with FcRn-driven half-life extension.
Fuchs E; Rudnik-Jansen I; Dinesen A; Selnihhin D; Mandrup OA; Thiam K; Kjems J; Pedersen FS; Howard KA
Acta Biomater; 2022 Nov; 153():411-418. PubMed ID: 36162760
[TBL] [Abstract][Full Text] [Related]
8. Proanthocyanidin from blueberry leaves suppresses expression of subgenomic hepatitis C virus RNA.
Takeshita M; Ishida Y; Akamatsu E; Ohmori Y; Sudoh M; Uto H; Tsubouchi H; Kataoka H
J Biol Chem; 2009 Aug; 284(32):21165-76. PubMed ID: 19531480
[TBL] [Abstract][Full Text] [Related]
9. Blueberry proanthocyanidins against human norovirus surrogates in model foods and under simulated gastric conditions.
Joshi S; Howell AB; D'Souza DH
Food Microbiol; 2017 May; 63():263-267. PubMed ID: 28040178
[TBL] [Abstract][Full Text] [Related]
10. Natural Polyphenols, 1,2,3,4,6-O-Pentagalloyglucose and Proanthocyanidins, as Broad-Spectrum Anticoronaviral Inhibitors Targeting Mpro and RdRp of SARS-CoV-2.
Jin YH; Lee J; Jeon S; Kim S; Min JS; Kwon S
Biomedicines; 2022 May; 10(5):. PubMed ID: 35625907
[TBL] [Abstract][Full Text] [Related]
11. Identification of 3-chymotrypsin like protease (3CLPro) inhibitors as potential anti-SARS-CoV-2 agents.
Mody V; Ho J; Wills S; Mawri A; Lawson L; Ebert MCCJC; Fortin GM; Rayalam S; Taval S
Commun Biol; 2021 Jan; 4(1):93. PubMed ID: 33473151
[TBL] [Abstract][Full Text] [Related]
12. Prediction of the Adult T-Cell Leukemia Inhibitory Activity of Blueberry Leaves/Stems Using Direct-Injection Electron Ionization-Mass Spectrometry Metabolomics.
Kai H; Okada Y; Goto Y; Nakayama T; Sugamoto K; Ogawa K; Yamasaki M; Morishita K; Matsuno K; Kunitake H
Plants (Basel); 2022 May; 11(10):. PubMed ID: 35631768
[TBL] [Abstract][Full Text] [Related]
13. Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.
Busnadiego I; Fernbach S; Pohl MO; Karakus U; Huber M; Trkola A; Stertz S; Hale BG
mBio; 2020 Sep; 11(5):. PubMed ID: 32913009
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of ACE2-Spike Interaction by an ACE2 Binder Suppresses SARS-CoV-2 Entry.
Shin YH; Jeong K; Lee J; Lee HJ; Yim J; Kim J; Kim S; Park SB
Angew Chem Int Ed Engl; 2022 Mar; 61(11):e202115695. PubMed ID: 35043545
[TBL] [Abstract][Full Text] [Related]
15. Identification of FDA approved drugs against SARS-CoV-2 RNA dependent RNA polymerase (RdRp) and 3-chymotrypsin-like protease (3CLpro), drug repurposing approach.
Molavi Z; Razi S; Mirmotalebisohi SA; Adibi A; Sameni M; Karami F; Niazi V; Niknam Z; Aliashrafi M; Taheri M; Ghafouri-Fard S; Jeibouei S; Mahdian S; Zali H; Ranjbar MM; Yazdani M
Biomed Pharmacother; 2021 Jun; 138():111544. PubMed ID: 34311539
[TBL] [Abstract][Full Text] [Related]
16. Current approaches for target-specific drug discovery using natural compounds against SARS-CoV-2 infection.
Khare P; Sahu U; Pandey SC; Samant M
Virus Res; 2020 Dec; 290():198169. PubMed ID: 32979476
[TBL] [Abstract][Full Text] [Related]
17. Shedding Light on the Inhibitory Mechanisms of SARS-CoV-1/CoV-2 Spike Proteins by ACE2-Designed Peptides.
Freitas FC; Ferreira PHB; Favaro DC; Oliveira RJ
J Chem Inf Model; 2021 Mar; 61(3):1226-1243. PubMed ID: 33619962
[TBL] [Abstract][Full Text] [Related]
18. Stapled Peptides Based on Human Angiotensin-Converting Enzyme 2 (ACE2) Potently Inhibit SARS-CoV-2 Infection
Curreli F; Victor SMB; Ahmed S; Drelich A; Tong X; Tseng CK; Hillyer CD; Debnath AK
mBio; 2020 Dec; 11(6):. PubMed ID: 33310780
[TBL] [Abstract][Full Text] [Related]
19. Withanone from
Balkrishna A; Pokhrel S; Singh H; Joshi M; Mulay VP; Haldar S; Varshney A
Drug Des Devel Ther; 2021; 15():1111-1133. PubMed ID: 33737804
[TBL] [Abstract][Full Text] [Related]
20. The use of Pseudotyped Coronaviruses for the Screening of Entry Inhibitors: Green Tea Extract Inhibits the Entry of SARS-CoV-1, MERSCoV, and SARS-CoV-2 by Blocking Receptor-spike Interaction.
Joseph J; Karthika T; Das VRA; Raj VS
Curr Pharm Biotechnol; 2022; 23(8):1118-1129. PubMed ID: 34375189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]